Expand CRBU Menu
CRBU MENU

CRBU Latest Press Releases

-- June 29, 2026 --

Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference Globe Newswire 8:00 AM

-- June 12, 2026 --

After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell Globe Newswire 8:10 AM

-- June 11, 2026 --

Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026 Globe Newswire 8:01 AM
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting Globe Newswire 8:00 AM

-- May 27, 2026 --

Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference Globe Newswire 4:05 PM

-- May 13, 2026 --

Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference Globe Newswire 4:05 PM

-- May 12, 2026 --

Caribou Biosciences to Highlight Vispa-cel and CB-011 Programs During Oral Presentations at the 2026 European Hematology Association (EHA) Annual Meeting Globe Newswire 9:30 AM

-- May 7, 2026 --

Caribou Biosciences Reports First Quarter 2026 Financial Results and Provides Business Update Globe Newswire 4:05 PM

-- May 5, 2026 --

Caribou Biosciences to Participate in the BofA Securities 2026 Health Care Conference Globe Newswire 4:05 PM

-- March 31, 2026 --

Caribou Biosciences Announces the FDA Granted Regenerative Medicine Advanced Therapy (RMAT) Designation to CB-011, an Allogeneic Anti-BCMA CAR-T Cell Therapy Globe Newswire 8:00 AM

-- March 5, 2026 --

Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Globe Newswire 4:05 PM
Market Data Delayed 15 Minutes